Drugmaker Valeant faces debt default risk; shares plunge 46 percent

[admin]

(Reuters) - Valeant Pharmaceuticals International Inc's shares plunged 46 percent on Tuesday after the company said a delay in filing its annual report put it in danger of a default on its $30 billion in debt.



More...